House Bill
H.R. 5237
Campaign Transparency Act
Primary Sponsor
Delia C. Ramirez
Representative
Cosponsors
4
Quick Stats
Policy Area
Summary
The Fentanyl Crisis Research and Evaluation Act requires the Government Accountability Office (GAO) to study the effects of the ongoing fentanyl crisis on government programs and finances. This report aims to provide Congress and the public with a better understanding of the wide-ranging impacts of the fentanyl epidemic.
Latest Action
Referred to the Subcommittee on Health.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Campaign Transparency Act
The Fentanyl Crisis Research and Evaluation Act requires the Government Accountability Office (GAO) to study the effects of the ongoing fentanyl crisis on government programs and finances. This report aims to provide Congress and the public with a better under
Community Breakdown
Pass
0%
Fail
0%
0 predictions
The Fentanyl Crisis Research and Evaluation Act requires the Government Accountability Office (GAO) to study the effects of the ongoing fentanyl crisis on government programs and finances. This report aims to provide Congress and the public with a better understanding of the wide-ranging impacts of the fentanyl epidemic.
- Bill Number
- 5237
- Sponsor
- Delia C. Ramirez (D-IL)
- Introduced
- 9/15/2025
- Status
- Referred to the House Committee on House Administration.
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- Campaign Transparency Act
- Bill Number
- 5237
- Sponsor
- Delia C. Ramirez (D-IL)
- Status
- Referred to the House Committee on House Administration.
- Introduced
- 9/15/2025
- Summary
- The Fentanyl Crisis Research and Evaluation Act requires the Government Accountability Office (GAO) to study the effects of the ongoing fentanyl crisis on government programs and finances. This report aims to provide Congress and the public with a better understanding of the wide-ranging impacts of
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.